The BioVendor Group development teams aim to fill the gaps between the existing range of parameters on the market.
Leading experts from the most innovative companies of the BioVendor Group cooperate on the development and production of immunoassays. Their common goal is to bring to the market the parameters that current diagnostics lacks. We want to create the conditions for more accurate laboratory diagnostics, bringing better care for patients around the world.
The synergy of our development teams creates unique know-how, allowing us to expand an already wide portfolio of parameters faster than ever before.
The CLIA immunoassay is based on the principle of magnetic particles and their ability to separate the immunocomplex with a selected antigen or antibody.
The detection system uses flash chemiluminescence using acridinium ester and the intensity of the light flash is measured in relative light units (RLU).
They use a specific design of reagent cartridge that is developed to optimize the stability of the reagents in the machine. Flexibility and traceability are ensured by RFID tags, while reliable handling without contamination is supplied by Dynamic Sealing Caps. The kit contains a reagent cartridge with magnetic particles and assay-specific solutions at working dilution, together with calibrators. The cartridge is easily inserted into the reagent rack and its disposable packaging is designed for continuous reagent consumption.
Finding new methods in the shape of our innovative kits is an integral part of the BioVendor Group's corporate culture. BioVendor Group’s CLIA portfolio includes 41 unique parameters - and we are always adding more.
Our experts have prepared a number of diagnostic panels that will make the test design as easy as possible for you. You can use the proposed diagnostic panel or build your own from a wide portfolio of CLIA assays. Perfect comfort and speed when entering tests provides the possibility of creating your own groups of parameters, which can be assigned to a sample with one click.
The CLIA solution opens up space for a more comprehensive examination of the patient and a more accurate diagnosis. The unique portfolio of both innovative and established parameters with CE IVD certification is a clear answer to the introduction of real personalized medicine.